Borealis Ventures is a leading venture capital firm that partners closely with exceptional entrepreneurs to build market-defining companies. With a focus on transforming healthcare through new therapies, digital innovation, and other technologies, Borealis Ventures is at the forefront of shaping the future of the industry. Since its founding in 2002, Borealis Ventures has played a pivotal role in the success of over 300 programs, creating a value of more than $8 billion. With deep roots in entrepreneurship at Dartmouth College, the firm brings a wealth of experience in early-stage investing to emerging companies across the United States and beyond. Borealis Ventures specializes in life science platforms, digital health, and animal health. As lifecycle investors, they work closely with syndicate partners to ensure that their portfolio companies have access to the necessary resources for growth and success. To learn more about Borealis Ventures and explore potential partnership opportunities, please reach out to them via phone at 603.643.1500 or email at [email protected].